NEOGENOMICS
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
NEOGENOMICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1998-10-29
Address:
Fort Myers, Florida, United States
Country:
United States
Website Url:
http://www.neogenomics.com
Total Employee:
501+
Status:
Active
Contact:
(239) 768-0600
Total Funding:
350.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Nginx Amazon ReCAPTCHA
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cure Forward
Cure Forward helps cancer patients and physicians access advanced treatments in oncology.
Gravity Diagnostics
Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing.
IceCure Medical Ltd.
IceCure is a medical device company setting new standards in minimally-invasive tumor therapy women’s health and interventional oncology.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Vireo Health
Vireo Health is a medical marijuana dispensary.
Current Advisors List
Board_member
2020-08-01
Current Employees Featured
Robert Gasparini Consultant @ NeoGenomics
Consultant
2014-08-01
Vincent Funari Vice President of Reasearch and Development @ NeoGenomics
Vice President of Reasearch and Development
2019-03-01
Kathryn B. McKenzie Chief Financial Officer @ NeoGenomics
Chief Financial Officer
Chris Smith CEO @ NeoGenomics
CEO
2022-07-01
Byron Shen Associate Director of Product Management, Pharma Services @ NeoGenomics
Associate Director of Product Management, Pharma Services
2021-05-01
Anna Juncker-Jensen Principal Scientist, Associate Director Academic Collaborations @ NeoGenomics
Principal Scientist, Associate Director Academic Collaborations
2021-03-01
Steven A. Ross Vice President, Chief Information Officer @ NeoGenomics
Vice President, Chief Information Officer
Lynn A. Tetrault Chair of the Board @ NeoGenomics
Chair of the Board
2022-03-01
Lawrence M. Weiss Chief Medical Officer @ NeoGenomics
Chief Medical Officer
Jennifer M. Balliet Chief Culture Officer @ NeoGenomics
Chief Culture Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-05 | Inivata | Inivata acquired by NeoGenomics | N/A |
| 2021-03-24 | Trapelo Health | Trapelo Health acquired by NeoGenomics | 65 M USD |
| 2018-10-23 | Genoptix | Genoptix acquired by NeoGenomics | N/A |
| 2015-10-21 | Clarient | Clarient acquired by NeoGenomics | N/A |
| 2014-07-08 | Path Logic | Path Logic acquired by NeoGenomics | 6 M USD |
Investors List
Woodline Partners
Woodline Partners investment in Post-IPO Equity - NeoGenomics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - NeoGenomics
Blue Water Life Science Fund
Blue Water Life Science Fund investment in Post-IPO Equity - NeoGenomics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - NeoGenomics
Soleus Capital
Soleus Capital investment in Post-IPO Equity - NeoGenomics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - NeoGenomics
First Light Asset Management
First Light Asset Management investment in Post-IPO Equity - NeoGenomics
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - NeoGenomics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - NeoGenomics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - NeoGenomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-26 | Inivata | NeoGenomics investment in Corporate Round - Inivata | 25 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.neogenomics.com Semrush global rank: 583 K Semrush visits lastest month: 79.21 K
- Host name: 45.60.0.166
- IP address: 45.60.0.166
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeoGenomics"
About | NeoGenomics Laboratories
NeoGenomics Laboratories has been serving patients for over 18 years, developing and delivering laboratory diagnostic and clinical trial services with a focus on cancer. …See details»
Our Team | NeoGenomics Laboratories
At NeoGenomics, innovation is one of our core values to ensure we provide one of the most comprehensive oncology-focused testing menus in the world. Our Scientific Advisory Board is …See details»
NeoGenomics - Crunchbase Company Profile & Funding
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, …See details»
Company Information :: NeoGenomics, Inc. (NEO)
NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, …See details»
Executive Team :: NeoGenomics, Inc. (NEO)
Chris joins NeoGenomics from OrthoClinical Diagnostics where he served as Chairman and CEO from 2019 to May of 2022. During his leadership, OrthoClinical raised $1.45 billion in funding …See details»
Board of Directors :: NeoGenomics, Inc. (NEO)
Chris joins NeoGenomics from OrthoClinical Diagnostics where he served as Chairman and CEO from 2019 to May of 2022. During his leadership, OrthoClinical raised $1.45 billion in funding in a Q1 2021 initial public offering …See details»
NeoGenomics - Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that …See details»
NeoGenomics Company Overview
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative …See details»
NeoGenomics Announces Chief Executive Officer Succession
Nov 5, 2024 MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading oncology testing services company, today announced …See details»
Patients | NeoGenomics Laboratories
Our organization is an integral part of the cancer care team by providing vital insights about a cancer’s diagnosis, prognosis, and therapy assignment. ... At NeoGenomics, we are extremely grateful to Sasha and her family for sharing …See details»
NeoGenomics Provides 2025 Financial Guidance and Updates …
2 days ago NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology …See details»
NeoGenomics - Funding, Financials, Valuation & Investors
NeoGenomics is registered under the ticker NASDAQ:NEO . Their stock opened with $5.00 in its Nov 12, 1999 IPO. NeoGenomics is funded by 13 investors. Woodline Partners and Federated …See details»
NeoGenomics Expands Board of Directors with Appointments of …
Jun 29, 2023 MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, …See details»
Corporate Stewardship | NeoGenomics Laboratories
NeoGenomics is committed to improving patient care through innovative cancer testing that helps inform cancer diagnoses and therapeutic prediction for every cancer patient. To help achieve …See details»
NeoGenomics - Contacts, Employees, Board Members, Advisors
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. Search Crunchbase Start Free TrialSee details»
NeoGenomics Announces Chief Executive Officer Succession
Jan 10, 2025 NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time. NeoGenomics Announces Chief …See details»
NeoGenomics Provides 2025 Financial Guidance and Updates …
2 days ago NeoGenomics is providing financial guidance 1 for 2025. The Company expects total revenues in the range of $735 million to $745 million and adjusted EBITDA in the range of $55 …See details»
NeoGenomics offers strong financial outlook, shares rise - The …
2 days ago NeoGenomics Inc. shared a strong financial outlook for 2025 and beyond. The Fort Myers-based cancer testing and research lab saw a sell-off of its shares last week.See details»
NeoGenomics Provides 2025 Financial Guidance and Updates
2 days ago NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology …See details»
NeoGenomics: Strong Revenue Growth and Strategic Initiatives …
1 day ago NeoGenomics, Inc. is a clinical laboratory, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the following two segments: …See details»